Wei Xu, Qingdao University Medical College, China Updates Copyright 2023 Huguenard, Cseresznye, Darcey, Nkiliza, Evans, Hazen, Mullan, Crawford and Abdullah
The SURMOUNT-1 trial published in the New England Journal of Medicine (Jastreboff et al., 2022) showed average weight loss of 20.9 percent of body weight at the highest tirzepatide dose over 72 weeks
Images of medication Wegovy Generic Name semaglutide Strength 2.4 mg/0.75 mL pre-filled pen-injector Availability Prescription only Drug Class GLP-1 Drugs CSA Schedule Not a controlled drug Labeler / Supplier Novo Nordisk National Drug Code (NDC) 00169-4524 More about Wegovy (semaglutide) Check interactions Compare alternatives Pricing & coupons Reviews (685) Drug images Latest FDA alerts (6) Side effects Dosage information During pregnancy Support group FDA approval history Drug class: GLP-1 Drugs Breastfeeding En espaol Patient resources Other brands Professional resources Other brands Related treatment guides Further information Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
If you are uncertain, check with your medical provider
This medication can be a good option for improving daily blood sugar stability